DELAYS IN BREAST CANCER DIAGNOSIS AT A TERTIARY CARE FACILITY IN KARACHI, PAKISTAN
Abstract
Background: Diagnostic delay of breast cancer is linked to poor prognosis and survival. It can be caused by patients or healthcare providers. Since there is no quantification of provider delay and total delay in Pakistan, the general picture of breast cancer diagnostic delay is poorly understood. Objectives: This study was conducted to quantify total delay, provider delay, and patient delay, along with the factors contributing to each type of delay in breast cancer management. Methods: This was a descriptive study conducted over 3 years at a hospital in Karachi. Convenience sampling was used. Breast cancer patients undergoing treatment were interviewed. Values for diagnostic delays extracted from literature were >12 weeks in seeking care as patient delay and >4 weeks in treatment initiation as provider delay. Result: A total of 334 patients were included in the analysis. Mean total delay was 56±52 weeks, the median (IQR) patient delay was 4 (0–22) weeks, and the median provider delay was 17 (9–52) weeks. Patient delay was found in 149 (44.6%), and provider delay was found in 269 (80.5%) patients. Believing symptoms to resolve on their own was the most common reason (24.9%) for patient delay. Seeking multiple opinions (43.7%) and misdiagnosis (43.4%) were the most common reasons for provider delay. Conclusion: Patients and providers both caused diagnostic delay in breast cancer treatment. There is a need to increase awareness in the general population and enhance the training of providers regarding timely recognition in all patients presenting with breast-related symptoms.References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424.
Zaheer S, Shah N, Maqbool SA, Soomro NM. Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, Pakistan: 2004–2025. BMC Public Health 2019;19(1):1001.
Breast Cancer - Statistics [Internet]. Cancer.Net. 2020 [cited 2020 Jun 14]. Available from: http://www.cancer.net/cancer-types/breast-cancer/statistics
Soomro R, Faridi S, Khurshaidi N, Zahid N, Mamshad I. Age and stage of breast cancer in Pakistan: An experience at a tertiary care center. J Pak Med Assoc 2018;68(11):1682–5.
Caplan L. Delay in breast cancer: implications for stage at diagnosis and survival. Front Public Health 2014;2:87.
Harris M, Thulesius H, Neves AL, Harker S, Koskela T, Petek D, et al. How European primary care practitioners think the timeliness of cancer diagnosis can be improved: a thematic analysis. BMJ Open 2019;9(9):e030169.
Ho PJ, Cook AR, Ri NKBM, Liu J, Li J, Hartman M. Impact of delayed treatment in women diagnosed with breast cancer: A population‐based study. Cancer Med 2020;9(7):2435–44.
Facione NC. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med 1993;36(12):1521–34.
Abu-Helalah AM, Alshraideh HA, Al-Hanaqtah M, Da'na M, Al-Omari A, Mubaidin R. Delay in presentation, diagnosis, and treatment for breast cancer patients in Jordan. Breast J 2016;22(2):213–7.
Shamsi U. Patient delay in breast cancer diagnosis, its associated factors and stage of breast cancer at first presentation. J Glob Oncol 2018;4(Suppl 2):12s.
Khan MA, Shafique S, Khan MT, Shahzad MF, Iqbal S. Presentation delay in breast cancer patients, identifying the barriers in North Pakistan. Asian Pac J Cancer Prev 2015;16(1):377–80.
Gulzar F, Akhtar MS, Sadiq R, Bashir S, Jamil S, Baig SM. Identifying the reasons for delayed presentation of Pakistani breast cancer patients at a tertiary care hospital. Cancer Manag Res 2019;11:1087–96.
Khan TM, Leong JPY, Ming LC, Khan AH. Association of knowledge and cultural perceptions of Malaysian women with delay in diagnosis and treatment of breast cancer: A systematic review. Asian Pac J Cancer Prev 2015;16(13):5349–57.
Li YL, Qin YC, Tang LY, Liao YH, Zhang W, Xie XM, et al. Patient and care delays of breast cancer in China. Cancer Res Treat 2019;51(3):1098–1106.
Khan A, Khan K, Raza A, Din Qureshi ZU, Sultan B, Khan FA. Patient self delay among women with breast cancer. J Ayub Med Coll Abbottabad 2018;30(4):558–61.
Baig M, Sohail I, Altaf HN, Altaf OS. Factors influencing delayed presentation of breast cancer at a tertiary care hospital in Pakistan. Cancer Rep (Hoboken) 2019;2(1):e1141.
Agodirin O, Olatoke S, Rahman G, Olaogun J, Kolawole O, Agboola J, et al. Impact of primary care delay on progression of breast cancer in a black african population: a multicentered survey. J Cancer Epidemiol 2019;2019:2407138.
Kumar A, Bhagabaty SM, Tripathy JP, Selvaraj K, Purkayastha J, Singh R. Delays in diagnosis and treatment of breast cancer and the pathways of care: a mixed methods study from a tertiary cancer centre in North East India. Asian Pac J Cancer Prev 2019;20(12):3711–21.
Unger-Saldaña K, Miranda A, Zarco-Espinosa G, Mainero-Ratchelous F, Bargalló-Rocha E, Lázaro-León JM. Health system delay and its effect on clinical stage of breast cancer: Multicenter study. Cancer 2015;121(13):2198–206.
Pace LE, Mpunga T, Hategekimana V, Dusengimana JM, Habineza H, Bigirimana JB. Delays in breast cancer presentation and diagnosis at two rural cancer referral centers in Rwanda. Oncologist 2015;20(7):780–8.
Pruitt L, Mumuni T, Raikhel E, Ademola A, Ogundiran T, Adenipekun A. Social barriers to diagnosis and treatment of breast cancer in patients presenting at a teaching hospital in Ibadan, Nigeria. Glob Public Health 2015;10(3):331–44.
Al-Shiekh SSA, Alajerami YS, Etewa BB, Elsous AM. System delay in breast cancer diagnosis in Gaza Strip, Palestine. J Oncol 2019;2019:5690938.
de Lemos LLP, Carvalho de Souza M, Pena Moreira D, Ribeiro Fernandes Almeida PH, Godman B, Verguet S, et al. Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis. PloS One 2015;14(10):e0224012.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
